Arovella Therapeutics prepares for key clinical milestones in cancer treatment

By Proactive Investors / July 28, 2024 / www.youtube.com / Article Link

Arovella Therapeutics Ltd (ASX:ALA) CEO and managing director Dr Michael Baker joins Proactive to recap a busy quarter of ...

Recent News

Strong Q1/26 results continue with Agnico, Kinross and Alamos reporting

May 04, 2026 / www.canadianminingreport.com

Gold stocks decline as equities reach all-time highs

May 04, 2026 / www.canadianminingreport.com

Gold stocks decline on metal pullback

April 27, 2026 / www.canadianminingreport.com

Newmont's Q1/26 earnings surge again even on production drop

April 27, 2026 / www.canadianminingreport.com

Mining still rules market over past six months

April 20, 2026 / www.canadianminingreport.com

See all >